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INTRODUCTION 
Cardiolipin (1,3-bis(sn-3’-phosphatidyl)sn-glycerol) (CL) is a 
unique glycerophospholipid of the energy transducing 
membranes of bacteria and mitochondria. Owing to its par-
ticular physicochemical properties, it plays an important 
role in the structural organization and the function of these 
membranes and strongly enhances the efficiency of the 
electron transport chain [1]. Biosynthesis of CL occurs at the 
bacterial cell membrane and the inner mitochondrial mem-
brane of eukaryotes, whereby two structurally and mecha-
nistically distinct types of CL synthases (CLS) can be distin-
guished: eukaryotes typically express CLS enzymes belong-
ing to the family of CDP-alcohol phosphatidyltransferases 
(CAP), which transfer the phosphatidyl moiety from CDP-di-
acylglycerol (CDP-DAG) to phosphatidylglycerol (PG) to syn-
thesize CL. In contrast, most bacterial CLS use a second mol-
ecule of PG to form CL, catalyzed by a phospholipase D 
(PLD)-type transphosphatidylation mechanism (reviewed in 
[2]). Exceptions from this classification are the CAP-type CLS 
of Streptomyces coelicolor and most likely other actinobac-
teria [3], and the PLD-type CLS of the unicellular eukaryote 
Trypanosoma brucei and all other trypanosomatids [4]. In 
addition, putative PLD-type CLS were identified bioinfor-
matically in the amoebozoan genus of Dictyostelium and in 
many genera of the group of alveolates, including  
Plasmodium and Toxoplasma [5,6] (reviewed in [7]). A  
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CAP – phosphatidyltransferases,  
CDP - cytidine diphosphate, 
CDP-DAG - CDP-diacylglycerol, 
CL – cardiolipin, 
CLS - cardiolipin synthase, 
DAG – diacylglycerol, 
PE – phosphatidylethanolamine, 
PG – phosphatidylglycerol, 
PLD - phospholipases D, 
TbCLS - T. brucei cardiolipin synthase. 
ABSTRACT  The glycerophospholipid cardiolipin is a unique constituent of  
bacterial and mitochondrial membranes. It is involved in forming and  
stabilizing high molecular mass membrane protein complexes and in maintain-
ing membrane architecture. Absence of cardiolipin leads to reduced efficiency 
of the electron transport chain, decreased membrane potential, and, ulti-
mately, impaired respiratory metabolism. For the protozoan parasite Trypano-
soma brucei cardiolipin synthesis is essential for survival, indicating that the 
enzymes involved in cardiolipin production represent potential drug targets.  
T. brucei cardiolipin synthase (TbCLS) is unique as it belongs to the family of 
phospholipases D (PLD), harboring a prokaryotic-type cardiolipin synthase 
(CLS) active site domain. In contrast, most other eukaryotic CLS, including the 
yeast ortholog ScCrd1, are members of the CDP-alcohol phosphatidyl 
transferase family. To study if these mechanistically distinct CLS enzymes are 
able to catalyze cardiolipin production in a cell that normally expresses a dif-
ferent type of CLS, we expressed TbCLS and ScCrd1 in CLS-deficient yeast and 
trypanosome strains, respectively. Our results show that TbCLS complemented 
cardiolipin production in CRD1 knockout yeast and partly restored wild-type 
colony forming capability under stress conditions. Remarkably, CL remodeling 
appeared to be impaired in the transgenic construct, suggesting that CL  
production and remodeling are tightly coupled processes that may require a 
clustering of the involved proteins into specific CL-synthesizing domains. In 
contrast, no complementation was observed by heterologous expression of 
ScCrd1 in conditional TbCLS knockout trypanosomes, despite proper  
mitochondrial targeting of the protein. 
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systematic phylogenetic analysis of CL synthases led to the 
conclusion that CAP-type CLS in eukaryotes were most likely 
inherited from endosymbiotic alpha proteobacteria, the mi-
tochondrial predecessors, whereas PLD-type CLS was al-
ready present in the first eukaryotic common ancestor [6]. 
Subsequently, the more recent CAP-type CLS replaced PLD-
CLS in the eukaryotic lineage from which multicellular eu-
karyotes emerged, while it got lost in the progenitors of the 
unicellular genera mentioned above [6]. Figure 1 depicts the 
two different biosynthetic mechanisms of CAP- and PLD-
type CL synthases and the domain organization of two rep-
resentative members.  
While it has been shown for several bacterial CLS, includ-
ing E. coli, Lactobacillus plantarum, and Bacillus ssp., that 
two molecules of PG are utilized to form CL (reviewed in [8]), 
more recent studies have identified alternative substrates 
of PLD-type CLS. In a mass spectrometry-based in vitro ac-
tivity assay of E. coli ClsC phosphatidylethanolamine (PE) 
was identified as the donor of the second phosphatidyl moi-
ety [9]. Interestingly, in addition to its CLS activity the pa-
ralog ClsB was found to also synthesize PG from PE and glyc-
erol [10]. In the plant pathogen Xanthomonas campestris, 
which contains six putative CLS genes, a PLD-type bifunc-
tional PE/CL synthase was identified and proposed to syn-
thesize PE from CDP-DAG and ethanolamine as well as CL 
from CDP-DAG and PG [11]. The substrates of PLD-type 
TbCLS have not been identified.  
The protozoan parasite T. brucei is endemic in sub-Sa-
haran Africa where it causes sleeping sickness in humans 
and nagana in livestock. Unlike E. coli or S. cerevisiae, which 
are viable without a functional CLS, T. brucei fails to survive 
in absence of TbCLS in culture [4], making TbCLS an interest-
ing drug target. In the context of a project to address the 
substrate utilization and mechanism of action of TbCLS, we 
studied whether PLD-type TbCLS and CAP-type S. cerevisiae 
CLS (ScCrd1) are able to functionally complement each 
other by introducing the genes into the respective (condi-
tional) knock-out strains. Cross-species complementation of 
the two mechanistically different types of CLS has not been 
reported before. 
RESULTS AND DISCUSSION 
TbCLS functionally complements Crd1-deficient  
Saccharomyces cerevisiae (crd1Δ) 
To assess the ability of TbCLS to complement ScCrd1-defi-
cient S. cerevisiae, we used the commercially available 
crd1Δ strain Y03840, which is viable under standard growth 
conditions but exhibits a growth defect when cultured at el-
evated temperature or on non-fermentable media [12]. To 
ensure correct and efficient mitochondrial targeting of 
TbCLS in S. cerevisiae, we fused the first 69 amino acids from 
the Fo-ATPase subunit 9 from Neurospora crassa (in this 
study abbreviated with Su9) [13,14] to the N-terminus of 
TbCLS. Su9-TbCLS and a C-terminally tagged form (Su9-
TbCLS-HA) were then expressed on an episomal plasmid in 
the CRD1-deleted strain (crd1Δ). As positive and negative 
controls for the phenotypic complementation analysis, 
crd1Δ cells were also transfected with the native ScCRD1 
gene and the empty expression vector. 
To confirm expression and mitochondrial targeting of Su9-
TbCLS, we analyzed protein extracts from whole cell lysates 
and isolated mitochondria from crd1Δ cells transfected with 
either the empty vector or Su9-TbCLS-HA by immunoblot-
ting. As shown in Figure 2A, a specific band at about 70 kDa 
was detected in both total lysate and mitochondria-en-
riched fraction of Su9-TbCLS-HA expressing cells. The appar-
ent molecular mass corresponds to the calculated molecular 
mass of TbCLS-HA of 74 kDa after cleavage of the Su9 tar-
geting peptide. 
To test functional complementation of crd1Δ by TbCLS, 
we first performed serial dilutions on SD-agar plates at 30°C 
and 37°C to compare growth and colony-forming capabili-
ties of wild-type, crd1Δ, crd1[CRD1] and crd1[Su9-TbCLS] 
strains. As shown in Fig. 2B, at 30°C all transformants grew 
equally well. In contrast, yeast cells lacking ScCrd1 (crd1Δ) 
and mutants transfected with the empty vector were unable 
to grow at 37°C. Interestingly, expression of Su9-TbCLS in 
crd1Δ yeast was able to restore proliferation and colony for-
mation on plates at 37°C at least partly. In contrast, despite 
proper expression and mitochondrial localization  
 
FIGURE 1: Types of cardiolipin (CL) synthases and their reaction mechanisms. (A) CLS belonging to the structural family of CDP-alcohol phos-
phatidyltransferases (CAP) catalyze an irreversible reaction between phosphatidyl glycerol (PG) and cytidine diphosphate diacylglycerol (CDP-
DAG) to form CL and CMP, whereas CLS of the phospholipase D (PLD) type catalyzes a reversible transphosphatidylation reaction, using one 
molecule of PG together with another phosphatidyl donor (PG, PE, see main text) to form CL. (B) Schematic representation of the domain 
arrangement of CLS from yeast (S. cerevisiae Crd1; CAP-type) and T. brucei (TbCLS; PLD-type). The predicted transmembrane domains and 
conserved functional domains are indicated. 
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(see Fig. 2A), Su9-TbCLS-HA was unable to restore growth 
and colony formation of crd1Δ[Su9-TbCLS-HA] trans-
formants at 37°C (data not shown), suggesting that the HA-
tag interfered with the function of TbCLS.  
To confirm CL synthesis by Su9-TbCls-expressing crd1Δ 
strains on a molecular level, we isolated lipids from sphero-
plasts and crude mitochondrial preparations and subjected 
them to MALDI-TOF MS (Matrix-Assisted Laser Desorp-
tion/Ionization-Time of Flight Mass Spectrometry) analysis. 
Figure 2C summarizes the observed CL molecular species 
distribution in extracts from wild-type, crd1Δ, crd1Δ[CRD1], 
and crd1Δ[Su9-TbCLS] strains from two independent exper-
iments. Representative spectra from wild-type, crd1Δ, and 
crd1Δ[Su9-TbCLS] strains are shown in Fig. 2D. The results 
show that wild-type yeast produced the full spectrum of CL 
molecular species reported before [15-17], with the most 
abundant species having fatty acyl chains with a total of 64, 
66, 68 and 70 carbon atoms and four unsaturated bonds per 
CL molecule (Fig. 2C, D). As expected, no CL molecular spe-
cies were detected in the m/z range of 1200 - 1500 in crd1Δ 
cells (Fig. 2D). In contrast, in Su9-TbCls-expressing crd1Δ 
cells, the CL molecular species with fatty acyl chains with 64, 
66, and 68 carbon atoms were present (Fig. 2D), demon-
strating that CL synthesis was restored by Su9-TbCls in these 
cells. However, the masses of the CL molecular species dif-
fered by 2 dalton between wild-type and Su9-TbCls-express-
ing crd1Δ cells. In wild-type yeast, the most prominent spe-
cies were at m/z 1372.2 (representing CL(66:4)) and 1400.3 
(representing CL(68:4)) while in crd1Δ cells complemented 
with Su9-TbCls the major species were at m/z 1374.7  
(representing CL(66:3)) and 1402.8 (representing CL(68:3)). 
The abundance of CL molecular species relative to other 
FIGURE 2: Expression, localization, and functionality of TbCLS in a S. cerevisiae crd1Δ background. (A) SDS-PAGE/immunoblot analysis using 
anti-HA antibodies of cell lysates (T) and mitochondria (M) prepared from crd1Δ cells transfected with the empty expression vector (V ctrl) or 
Su9-TbCLS-HA (TbCLS-HA). Antibodies against the cytosolic protein p20 and mitochondrial porin Por1 were used as controls. (B) Growth and 
colony formation in serial dilutions of S. cerevisiae wild-type (WT), crd1Δ, and crd1Δ cells expressing Su9-TbCLS, Crd1, or the empty expression 
vector. Plates were incubated in parallel at 30°C and 37°C for 4 days. (C) Cardiolipin (CL) species composition of wild-type (WT), crd1Δ (-), Crd1 
addback (CRD1), and TbCLS complemented crd1Δ cells (TbCLS). Lipid extracts from crude mitochondrial membranes (Exp. I) or spheroplasts 
(Exp. II) were analyzed by MALDI-TOF mass spectrometry in two independent experiments. Molecular species are defined by the total number 
of carbon atoms in the acyl chains and the number of unsaturated bonds within the acyl chain. Identified species are marked in dark grey, 
minor species are in light gray; only one analysis was done with the CRD1 addback sample (indicated by diagonal lines). (D) Representative full-
range mass spectra from experiment II; the insets highlight the m/z range of the cardiolipin molecular species of wild-type (WT, top panel) and 
TbCLS-complemented crd1Δ cells (crd1Δ [TbCLS], bottom panel); no cardiolipin species are detected in crd1Δ cells (middle panel). 
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phospholipids was substantially lower in Su9-TbCls comple-
mented cells compared to wild-type or crd1Δ[CRD1] cells, 
suggesting that the expression level or activity of Su9-TbCls 
was lower than that of ScCrd1. 
The prevalence of triple-unsaturated CL species is remi-
niscent of the CL molecular species composition of the cld1Δ 
and, to some extent, taz1Δ mutants, in which remodeling of 
premature CL species is impaired due to the absence of the 
CL-specific deacylase ScCld1 [17,18] or tafazzin [17,19]. De-
ficient CL remodeling in Su9-TbCls-complemented cells may 
have different reasons: i) In wild-type yeast, ScCrd1 may be 
confined to specific domains within the inner mitochondrial 
membrane, possibly physically interacting with ScCld1  
deacylase, or any other component of the remodeling ma-
chinery. In contrast, the heterologous enzyme TbCLS may 
not be directed to that specific microenvironment and a 
specific interaction with remodeling enzymes may be ab-
sent or deficient, resulting in the lack of CL remodeling.  
ii) ScCld1-mediated remodeling may only occur if CL levels 
reach a certain threshold. In Su9-TbCls-expressing cells, this 
threshold may not be reached.  
 
ScCrd1 does not complement a conditional TbCLS knockout 
cell line 
In contrast to yeast, CL synthesis in trypanosomes is essen-
tial for cell proliferation and survival [4]. To test whether 
ScCrd1 could functionally replace TbCLS, we expressed 
ScCrd1 in a conditional TbCLS knockout cell line of T. brucei 
procyclic forms, where the expression of the ectopic TbCLS 
recovery gene can be switched off by removing tetracycline 
from the growth medium [4]. Using plasmids pGS-
CRD1ΔLIIβ and pGS-CRD1-cMyc (details see experimental 
procedures), wild-type ScCRD1 or cMyc-tagged ScCRD1 
were stably integrated into the conditional TbCLS knockout 
genome along with the selectable marker gene SAT1  
(conferring nourseothricin resistance) and under the control 
of a constitutively active procyclin promoter. Transformed 
cells were selected in the presence of the antibiotic nourse-
othricin after limiting dilution in 24-well plates and geno-
typed by PCR. 
Transcription of untagged ScCrd1 was examined by RT-
PCR, confirming the presence of ScCrd1 mRNA. Expression 
of cMyc-tagged ScCrd1 on a protein level was confirmed by 
SDS-PAGE and immunoblotting of protein extracts from cells 
transformed with ScCRD1-cMyc (Fig. 3A). The subcellular lo-
calization of ScCrd1-cMyc in T. brucei was analyzed by im-
munofluorescence microscopy using antibodies against the 
cMyc epitope and against a protein of the archaic trans-
locase of the outer mitochondrial membrane (ATOM) as mi-
tochondrial marker [20]. The results showed that the tagged 
protein is properly targeted to the mitochondrion, exhibit-
ing the characteristic tubular staining throughout the cell 
(Fig. 3B). 
To test viability of the transformants in absence of TbCLS, 
tetracycline was removed from the culture medium to ab-
late TbCLS expression [4]. Growth curves of two clones ex-
pressing ScCrd1 grown in presence or absence of tetracy-
cline were recorded and showed that ScCrd1 was unable to 
sustain parasite growth (Fig. 3C). Similar to TbCLS condi-
tional knock out cells, proliferation in absence of tetracy-
cline ceased after 48 h, followed by a continuous decrease 
in cell number and death of the culture. A similar observa-
tion was made for trypanosomes expressing cMyc-tagged 
ScCrd1 (not shown). Together, these data show that both 
untagged and tagged ScCrd1 are unable to complement 
growth of T. brucei procyclic forms after ablation of TbCLS, 
despite proper mitochondrial localization. 
Several reasons for the inability of ScCrd1 to complement 
TbCLS in T. brucei are conceivable. Firstly, failure to cleave 
the mitochondrial targeting peptide in T. brucei may impair 
enzyme activity. As predicted by TargetP 1.1 [21,22], ScCrd1 
comprises a targeting signal with a cleavage site at Y53,  
FIGURE 3: Expression, localization, 
and functionality of ScCrd1 in T. 
brucei TbCLS conditional knockout 
cells. (A) SDS-PAGE/immunoblot 
analysis of whole-cell extracts from 
wild-type (WT) and Crd1-cMyc-ex-
pressing parasites using anti-cMyc 
antibodies. (B) Immunofluores-
cence microscopy using antibodies 
against the endogenous mitochon-
drial outer membrane protein 
ATOM (red) and cMyc-tagged 
ScCrd1 (green). The overlay of both 
channels (merge) shows overlap-
ping signals (yellow). DIC, Differen-
tial Interference Contrast. (C) 
Growth curve of conditional TbCLS 
knockout cells expressing ScCrd1. 
Two different clones (black and 
green lines) were cultured in the 
presence (solid lines) or absence 
(dashed lines) of tetracycline (tet) 
to maintain or ablate, respectively, 
TbCLS expression. 
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resulting in a calculated molecular mass of 25.75 after pro-
teolytic processing. Since the observed apparent molecular 
mass of cMyc-tagged ScCrd1 (Fig. 3A) likely corresponds to 
the molecular mass of the full-length protein (32.02 kDa) 
plus the C-terminal triple-cMyc tag (6.32 kDa), it is possible 
that ScCRD1 is not proteolytically processed in T. brucei par-
asites and may not be (fully) active. 
Secondly, the finding that ScCrd1 in S. cerevisiae is em-
bedded in a protein complex and that its activity is substan-
tially reduced upon purification [23] suggests that ScCrd1 
depends on the presence of other proteins for optimal func-
tion. These proteins may be missing in T. brucei or may not 
associate with ScCrd1. Conversely, since TbCLS is also part 
of a larger mitochondrial complex [4], it is possible that 
ScCrd1 is excluded from such a complex and, thus, from in-
teracting with partners that are essential for CL formation in 
T. brucei. 
Thirdly, Crd1 may not have access to its substrates, CDP-
DAG and PG. It is known that the orientation of CLS differs 
between E. coli and mammals. While the active site of E. coli 
CLS is most likely directed towards the periplasm [24], CLS 
from rat liver mitochondria was shown to face the matrix 
side [25]. Accordingly, being a homologue of bacterial CLS, 
the active site of TbCLS may be facing the intermembrane 
space while ScCrd1 may face the matrix. Thus, access of 
ScCrd1 to its substrates in T. brucei may be impaired. In ad-
dition, no mitochondrial CDP-DAG synthase has been iden-
tified in T. brucei [26], implying that CDP-DAG as precursor 
for PG and CL synthesis would have to be transported from 
the endoplasmic reticulum to the inner mitochondrial mem-
brane, a pathway that has not been demonstrated in T. 
brucei. Thus, it is possible that ScCRD1 may not be active 
since it has no access to its substrate CDP-DAG. Note that 
bacterial-type CLS do not depend on CDP-DAG as substrate 
for CL synthesis, i.e. a lack of mitochondrial CDP-DAG may 
not hamper CL formation by TbCLS in T. brucei. 
 
Summary 
In this study we investigated the ability of two structurally 
non-related forms of eukaryotic CL synthases to functionally 
complement each other in cells lacking the native CLS. We 
found that PLD-type TbCLS is functional in yeast, alleviating 
the proliferation deficiency of CRD1 knockout cells under 
stress conditions, whereas CAP-type ScCrd1 fails to substi-
tute the essential function of TbCLS in trypanosomes.  
We observed that CL produced by TbCLS in yeast contains 
less unsaturated fatty acids compared to natural mature CL 
of S. cerevisiae. A similar shift to a higher degree of satura-
tion also occurs in CL from yeast strains with deficient CL-
remodeling. The apparent lack of CL maturation in TbCLS-
complemented crd1Δ cells suggests that biosynthesis and 
remodeling are tightly coupled processes, probably depend-
ing on a specific microenvironment and proper targeting of 
the involved proteins to specialized membrane domains. 
The non-homologous TbCLS may lack the property to local-
ize correctly to such a microdomain or physically interact 
with the remodeling machinery.  
 
 
MATERIALS AND METHODS 
Reagents 
All reagents were of analytical grade and, unless otherwise 
stated, purchased from Merck-Sigma Aldrich (Buchs, Switzer-
land). Kits for plasmid DNA extractions and PCR purification, Pfu 
polymerase and T4 DNA ligase were from Promega (Dübendorf, 
Switzerland). Restriction enzymes were purchased from Ther-
moFisher Scientific (Reinach, Switzerland). Home-made chemi-
cally competent E. coli XL-1 were used for molecular cloning. 
Growth media were prepared in the lab except for SDM79, for 
which a customized medium powder mix (Amimed®SDM79) 
was purchased from BioConcept (Allschwil, Switzerland). 
 
T. brucei strains, plasmids and growth media 
The procyclic form TbCLS conditional knockout cell line contain-
ing a tetracycline-inducible copy of C-terminally hemagglutinin-
tagged TbCLS has been described before [4].  
For stable integration of ScCRD1 or ScCRD1-cMyc into the 
TbCLS conditional knock-out cell line, plasmid pG-EGFPΔLIIβ 
[27] (kindly provided by Isabel Roditi, University of Bern, Bern, 
Switzerland) was used as backbone after replacing the neomy-
cin (NEO) resistance marker by the nourseothricin resistance 
gene SAT1. pKOS [28] was taken as template for the amplifica-
tion of SAT1. The triple-cMyc tag with flexible linker sequence 
to generate cMyc-tagged CRD1 was PCR-amplified from the 
vector pJM1 (kindly provided by Jan Mani, University of Bern, 
Bern, Switzerland).  
TbCLS conditional knockout parasites were cultured at 27°C 
in SDM79 supplemented with 15% (vol/vol) heat-inactivated 
FBS (GibcoTM, ThermoFisher Scientific, Reinach, Switzerland), 
160 µM hemin, 90 µM folic acid, 15 µg/ml G418, 2 µg/ml puro-
mycin, 5 µg/ml blasticidin, 0.2 µg/ml phleomycin, and 1 µg/ml 
tetracycline to induce the expression of ectopic TbCLS. ScCRD1-
complemented TbCLS conditional knockout cells were cultured 
in the same medium with an additional 150 µg/ml nourseothri-
cin (Jena Biosciences, Jena, Germany). 
 
Yeast strains, plasmids, and growth media 
Designer deletion strain BY4741, referred to as wild type (WT) 
strain in this study, was used as control strain. The haploid 
crd1Δ (ORF YDL142c) strain Y03840 (BY4741; MATa; ura3Δ0; 
leu2Δ0; his3Δ1; met15Δ0; YDL142c::kanMX4) created in the 
course of the Saccharomyces Genome Deletion Project was 
purchased from Euroscarf and was used to test functional com-
plementation with TbCLS.  
The yeast episomal plasmid (YEp) pVT-H, a modified version 
of expression vector pVT-U [29] in which the URA3 selection 
marker had been replaced by HIS3, was used for complementa-
tion of strain Y03840 with TbCLS. Another high copy number 
YEp, pDR197 (kindly provided by Doris Rentsch, University of 
Bern, Switzerland [30]) was used for the addback expression of 
ScCRD1 in strain Y03840.  
Standard YPD growth medium YPD agar plates were used for 
general culture and maintenance of S. cerevisiae strains. For se-
lections and large cultures of auxotrophic transformants, syn-
thetic defined drop-out media (SD/DO) were used, composed 
of 0.67% yeast nitrogen base without amino acids, 2% dextrose, 
and the appropriate amino acids according to the Yeast  
Protocols Handbook (Clontech Laboratories) [31]. 
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ScCRD1 constructs for complementation of T. brucei CLS 
knock-out cells 
Exchange of resistance marker of pG-EGFPΔLIIβ [32]: SAT1 was 
amplified by PCR from plasmid pKOS using primer 1 and 2 (see 
table S1), digested with NheI and ClaI (dam sensitive) and li-
gated into the equally digested vector pG-EGFPΔLIIβ isolated 
from dam E. coli strain GM48. The resulting vector was named 
pGS-EGFPΔLIIβ.  
ScCRD1 was amplified by PCR from isolated genomic DNA 
from strain BY4741 using primer 3 and 4 that were designed to 
replace EGFP from pGS-EGFPΔLIIβ by CRD1 flanked by new mul-
tiple cloning sites. 
For the construction of CRD1-cMyc, CRD1 was first amplified 
using primer 5 and 6 from pGS-CRD1, digested with HindIII and 
BamHI and ligated into equally digested vector pJM1, fusing 
CRD1 to a C-terminal triple-cMyc-tag. The fusion-sequence was 
subsequently PCR-amplified again using primer 5 and 7 fol-
lowed by digestion with HindIII and PstI. Ligation with 
HindIII/PstI digested pGS-EGFPΔLIIβ resulted in pGS-CRD1-
cMyc.  
The resulting vectors pGS-CRD1 and pGS-CRD1-cMyc con-
tained CRD1(-cMyc) and SAT1 under the control of the consti-
tutively active procyclin promoter and a modified procyclin 3’ 
UTR. Digestion with KpnI and NotI allows genomic integration 
of the construct via homologous recombination with a  
procyclin locus. 
 
TbCLS and ScCRD1 constructs for complementation of yeast 
crd1Δ 
ORF Tb427.4.2560, encoding TbCLS, was amplified from puri-
fied genomic DNA from T. brucei strain Lister 427 by PCR using 
primers 8 and 9 for the untagged copy and primer 10 for the 
construction of a C-terminally HA-tagged version. In both ver-
sions the thymidine base of the BamHI restriction site close to 
the end of the TbCLS ORF was mutated to cytidine.  
The Fo-ATPase subunit 9 from Neurospora crassa, in this 
study abbreviated with Su9, was PCR-amplified using primers 
11 and 12 from template plasmid pGEM4 Su9(1-69)-DHFR [33]. 
The fusion-sequence was obtained by sequential ligation of Su9 
and TbCLS-HA into the multiple cloning site of pDR197, result-
ing in the expression vector pDR-Su9TbCLS-HA.  
For the expression of an addback copy of ScCRD1 in crd1Δ, 
ORF YDL142c from S. cerevisiae was amplified by PCR from iso-
lated genomic DNA from strain BY4741 using primers 13 and 14 
and ligated into pDR197. 
For the construction of untagged pVT-H-Su9TbCLS con-
structs, the Su9 fusion sequences were PCR-amplified from 
pDR-Su9TbCLS-HA using primers 15 and 16, digested with 
BamHI and XbaI and ligated into equally digested pVT-H. 
 
Stable transformation of trypanosomes 
Trypanosomes were grown to mid-log phase, harvested by cen-
trifugation and resuspended in trypanosome transformation 
buffer [34] (90 mM sodium phosphate, 5 mM potassium chlo-
ride, 0.15 mM calcium chloride, 50 mM HEPES, pH 7.3) previ-
ously mixed with 10 µg of linearized DNA per 4 x 107 cells. Elec-
troporation was performed in 100 µl Nucleocuvettes™ using a 
Lonza 4D-Nucleofector™ (X-unit, pulse code FI-115, primary 
cells P3) as described in [35]. Transformed cells were allowed 
to recover in standard growth medium without antibiotics dur-
ing 24 h before limiting dilution and selective culture in pres-
ence of all previously used antibiotics and additional 150 µg/ml 
nourseothricin. 1 µg/ml tetracycline was added immediately af-
ter transformation and in all subsequent dilutions to keep the 
expression of ectopic TbCLS. 
 
Stable transformation of yeast 
Transformation of yeast was performed according to the high 
efficiency transformation protocol by Gietz & Woods (2002) 
[36]. Briefly, cells were grown to a density of approximately  
2 x 107 cells/ml and then washed in sterile water. Aliquots of 
108 cells were transferred to 1.5 ml tubes, pelleted and resus-
pended in 360 µl of transformation mixture containing 240 µl 
50% PEG 3500 (w/v), 36 µl 1 M LiOAc, 50 µl 2.0 mg/ml single-
stranded carrier DNA, 34 µl plasmid DNA (0.1 - 10 µg). Following 
incubation at 42°C for 40 min, cells were pelleted in a microcen-
trifuge, gently resuspended in 1 ml sterile water and plated 
onto selective medium. 
 
Determination of growth phenotype  
Functional complementation of the crd1Δ strain by TbCls was 
analyzed by making use of the temperature sensitive pheno-
type of the crd1Δ strain. Yeast WT, crd1Δ, crd1Δ[CRD1], 
crd1Δ[Su9-TbCLS], and crd1Δ [empty vector] strains were cul-
tured in SD complete or the appropriate drop-out medium to 
an optical density (OD600) of 0.1, serially diluted by factors of 
ten and spotted on SD complete agar plates. Plates were incu-
bated at 30°C or 37°C for 3 - 4 days and growth of the respective 
strains was compared between control (30°C) and stress (37°C) 
temperature. 
 
Phospholipid extraction and mass spectrometry  
Yeast spheroplasts and mitochondria-enriched fractions were 
prepared according to Gregg et al. [37]. Generally, yeast cul-
tures were grown to an optical density (OD600) of 0.8 - 2, 
washed 2 x with water and incubated in buffer containing  
100 mM Tris/H2SO4 (pH 9.4) and 10 mM dithiothreitol [2 ml/g 
(wet weight) cells] for 20 min at 30°C with gentle shaking. Sub-
sequently, cells were pelleted, washed, and resuspended in zy-
molyase buffer [20 mM potassium phosphate (pH 7.4), 1.2 M 
sorbitol] [7 ml of buffer/g (wet weight) cells]. 2 mg/g (wet 
weight) cells of zymolyase 20-T (AMS Biotechnology, UK) was 
added and the suspension was incubated with gentle shaking 
at 30°C until the OD600 reached 20% of the initial value (20 - 40 
min). Isolation of crude mitochondria was done exactly follow-
ing the protocol of Gregg et al. [37]. 
Lipids were extracted from washed spheroplasts (zymolyase 
buffer without zymolyase) or crude mitochondria using a mod-
ification of the protocol published by Bligh and Dyer [38]: sphe-
roplasts from up to 1 l of culture were resuspended in 8 ml 
0.1 N HCl and transferred to a 250 ml Erlenmeyer flask contain-
ing 20 ml chloroform and 40 ml methanol. After incubation and 
shaking at room temperature for 1 hour, 20 ml chloroform, fol-
lowed by 20 ml 0.1 N HCl were added under vigorous shaking. 
Phase separation was obtained after centrifugation at 2000 x g 
for 15 min. The organic phase was collected, dried under a 
stream of nitrogen and washed 1 x with a mixture of 
0.1 N HCl:chloroform:methanol (0.8:2:2, by vol.). The washed 
and dried organic phase was dissolved in 1 ml  
chloroform: methanol (2:1, by vol.) and subjected to mass  
spectrometry. 
MALDI-TOF MS was performed according to Angelini et al. 
(2012) [19] using a Bruker Microflex LRF instrument. 
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Protein extraction, SDS-polyacrylamide gel electrophoresis 
and immunoblotting 
Trypanosomes grown to a concentration of 107 cells/ml were 
harvested by centrifugation, washed with Tris-buffered saline 
(TBS; 10 mM Tris-HCl, pH 7.5, 144 mM NaCl) and resuspended 
in SoTE buffer (20 mM Tris-HCl, pH 7.5, 600 mM sorbitol, and 
2 mM EDTA) to a concentration of 108 cells/ml. Digitonin was 
added to the cell suspension at a final concentration of 
0.25 mg/ml to lyse the cells. After incubation on ice for 5 min, 
non-solubilized membranes (including mitochondria) and cell 
debris were pelleted by centrifugation at 7000 x g in a table-top 
centrifuge, resuspended in sample buffer containing 2.5% SDS 
and boiled at 95°C for 5 min.  
Yeast proteins from whole cells were extracted according to 
Kushnirov (2000) [39]: Cells were pelleted, washed once with 
distilled water, and resuspended in 0.1 M NaOH (200 µl/2 mg 
of wet weight pellet). After incubation at room temperature for 
5 min, cells were pelleted by centrifugation, resuspended in 
SDS-sample buffer, and heated at 50°C for 5 min. Proteins from 
yeast mitochondria were extracted by suspension of the mito-
chondria-enriched fraction in SDS-sample buffer and heating at 
50°C for 5 min.  
Proteins were separated on 12% polyacrylamide gels and 
transferred to polyvinylidene difluoride membranes (Millipore) 
by semi-dry blotting (Bio-Rad). Tagged proteins were visualized 
on films using SuperSignal West Pico (Pierce) chemiluminescent 
substrate after incubation with tag-specific primary antibodies 
and horseradish peroxidase-conjugated secondary antibodies. 
Antibodies used in this study were: mouse monoclonal anti-
body anti-cMyc (9E10; Santa Cruz Biotechnology, USA; dilution 
1:1000 in TBS containing 5% skimmed milk); mouse monoclonal 
antibody anti-HA (HA11; Enzo Life Sciences, USA; dilution 
1:3000 in TBS/5% milk); rat polyclonal anti-p20 antibody [40] 
(kindly provided by M. Altmann, Institute for Biochemistry and 
Molecular Medicine, University of Bern, Switzerland; dilution 
1:1000 in TBS/5% milk); rabbit anti-porin antibody (kindly pro-
vided by R. Schneiter, Department of Biology, University of Fri-
bourg, Switzerland; dilution 1:5000 in TBS/5% milk); rat anti-
mouse HRP-conjugated secondary antibody (DAKO-Agilent, 
Switzerland; dilution 1:5000 in TBS/5% milk); goat anti-rat HRP-
conjugated secondary antibody (Invitrogen; dilution 1:10000 in 
TBS/5% milk). 
 
Immunofluorescence microscopy of trypanosomes 
Slides for immunofluorescence microscopy of trypanosomes 
were prepared as described in [41]. Permeabilized and blocked 
[phosphate buffered saline (PBS) containing 5% skimmed milk 
powder] cells were incubated for 45 min with primary antibod-
ies against cMyc (dilution 1:250 in blocking solution) and the 
mitochondrial outer membrane protein ATOM (archaic trans-
locator of the outer membrane) (rabbit polyclonal anti-ATOM 
antibody, kindly provided by André Schneider, Department of 
Chemistry and Biochemistry, University of Bern, Switzerland; 
dilution 1:1000 in blocking solution). After washing, fluorescent 
secondary antibodies Alexa Fluor® goat anti-mouse 488 and 
goat anti-rabbit 594 (Invitrogen™, diluted 1:1000 in blocking so-
lution) were added for another 45 min. Following washing with 
PBS, slides were dried and coverslips were mounted with Vec-
tashield® containing 4’, 6-diamidino-2-phenylindole [DAPI 
(Vector Laboratories), Reactolabs, Servion, Switzerland].  
Fluorescence microscopy was performed with a Leica 
DM 16000 B inverted microscope using a 60 x immersion objec-
tive and pictures were acquired using a connected Leica 
DFC360 FX camera. Image deconvolution and further pro-
cessing was performed using Leica LAS X software and Fiji (NIH), 
respectively. 
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